Therapeutic substitution refers to dispensing a drug that is chemically different from, but considered clinically comparable to, the medication a prescriber originally ordered — for example, substituting within the same drug class rather than dispensing an identical generic version of the exact molecule prescribed. This is distinct from generic substitution, where the substituted product contains the same active ingredient in the same form.
Because therapeutic substitution changes what the patient actually receives relative to the prescriber’s specific order, it sits under tighter regulatory control than routine generic substitution. Some form of pre-established authorization is typically required before a pharmacist can make this kind of swap — this might come through a collaborative practice agreement, a formulary policy at a health system, or a specific statutory allowance, depending on the setting and the state.
Why it matters
Pharmacists run into therapeutic substitution questions most often in hospital and health-system settings with formulary management programs, though the concept also surfaces in outpatient contexts where state law permits limited substitution for cost or supply reasons. Understanding whether a given substitution is permitted — and what authorization or documentation it requires — is a core scope-of-practice question, and the answer depends heavily on the practice setting and the state’s specific rules.
This entry describes the general concept only; it is not guidance for any specific substitution decision. RxByState tracks how each state authorizes and limits therapeutic substitution — see https://app.rxbystate.com/signup.